DIGITAL HEALTH

April 28, 2022

DIGITAL HEALTH

The authors would like to express their gratitude to those who contributed to this research either by participating in the surveys carried out during the EIT Health Morning Health Talks or the in-depth interviews. 

Spotlight

USV PRIVATE LIMITED

We are a 55 year old leading healthcare company which began as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. Our product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables. These are manufactured in our cGMP compliant plants located in India. We market our products globally to 75 countries. In the financial year 2015-16, our total income was Rs 25,445 million. Our Indian business contributed 82% to the revenue and the rest was from export of APIs and Finished Dosages. In India we are recognised for our leadership in the Oral Anti-Diabetic market where we rank No. 1 by Rx and Value. In the Cardiovascular diseases segment we are No. 1 by Rx and rank no. 6 by Value . We also have a significant presence in the areas of Vitamins, Minerals, Nutrients, Dermatology, Gastroenterology and CNS.

OTHER WHITEPAPERS
news image

Testing the EMR and Beyond

whitePaper | October 5, 2021

At every stage of a patient’s well-being, different forms of technology and software support the expansion of better healthcare. As the reliance on technology grows, ensuring that these lifesaving systems don’t break under the strain is imperative. To keep operations running smoothly, healthcare IT professionals must perform regular and exhaustive testing. Fortunately, the introduction of automation, robotics, and artificial intelligence (AI) has made testing easier to deliver. In this eBook, you will discover how these technological developments help optimize processes, integrate workflows, and improve the performance of systems and medical devices.

Read More
news image

Improve Clinical Workflow, Reduce Costs with Purpose-Built Devices for Healthcare

whitePaper | February 6, 2020

Improving telehealth success with Healthcare specific devices. One of the primary challenges faced by clinicians with telehealth appointments is effectively and efficiently bringing both parties together without any breakdown in communication. Therefore, it's imperative that the hardware being utilized can support excellent audio with noise cancelling features, hi-res video and integrated hi-def cameras - without these items’ physicians are left with a good idea of the issue at hand but no way to implement.

Read More
news image

Australia’s health reimagined

whitePaper | March 11, 2022

Following the emergence of COVID-19 and significant foundational investment in digital health infrastructure, Australia’s health system, like all health systems globally, is rapidly building momentum towards a digital future.

Read More
news image

Smarter Workflows and Technology to Improve Care Management Outcomes

whitePaper | December 6, 2021

Do you struggle to deliver efficient, effective care management services? If you answered yes, you're not alone. But don't let outdated processes, insufficient technology tools and tedious manual processes hamper your efforts.

Read More
news image

Personalizing Radiotherapy in Oncology: The Evolution of Treatment

whitePaper | January 9, 2020

Radiation therapy is one of the most common treatments used to fight cancer in the U.S., with more than half of cancer patients receiving it either alone or in combination with other medical interventions.1 With the traditional approach to radiation therapy, the dose and schedule is tailored to the tumor type, location, and stage of growth, but only infrequently updated in light of changes after treatment starts. Experts in adaptive therapy are looking to deliver a more personalized treatment strategy guided by the individual patient’s needs.

Read More
news image

Future of medical science

whitePaper | May 14, 2022

Medical science is currently being transformed by scientific discoveries that will dramatically advance the way we diagnose and treat different diseases.

Read More

Spotlight

USV PRIVATE LIMITED

We are a 55 year old leading healthcare company which began as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. Our product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables. These are manufactured in our cGMP compliant plants located in India. We market our products globally to 75 countries. In the financial year 2015-16, our total income was Rs 25,445 million. Our Indian business contributed 82% to the revenue and the rest was from export of APIs and Finished Dosages. In India we are recognised for our leadership in the Oral Anti-Diabetic market where we rank No. 1 by Rx and Value. In the Cardiovascular diseases segment we are No. 1 by Rx and rank no. 6 by Value . We also have a significant presence in the areas of Vitamins, Minerals, Nutrients, Dermatology, Gastroenterology and CNS.

Events